Aankondiging • Jun 24
JSR Corporation(TSE:4185) dropped from FTSE All-World Index (USD) JSR Corporation(TSE:4185) dropped from FTSE All-World Index (USD) Aankondiging • Jun 08
JSR Corporation to Delist from Prime Section of Tokyo Stock Exchange, Effective June 25, 2024 JSR Corporation will be delisted from Prime Section of Tokyo Stock Exchange effective from June 25, 2024 due to Reverse stock split. Aankondiging • May 09
JSR Corporation Announces Board Resignations JSR Corporation announced resignations of Tadayuki Seki, David Robert Hale, Masato Iwasaki and Kazuo Ushida as Outside Directors; Koichi Hara (Managing Officer, Corporate Planning (including supervising group companies), M&A), Seiji Takahashi (Managing Officer, Manufacturing, Procurement and Logistics, Yokkaichi Plant Manager), Ichiko Tachibana (Senior Officer, Legal Affairs, Compliance, General Affairs, Secretarial Office) and Kenichi Emoto (Officer, Accounting, Finance (CFO), Corporate Communications) as Directors; Tomoaki Iwabuchi as Standing Audit & Supervisory Board Member; Junko Kai and Takaaki Tokuhiro as Outside Audit & Supervisory Board Members. Aankondiging • May 03
JSR Corporation to Be Delisted from the Tokyo Stock Exchange's Top-Tier Prime Section JSR Corp. said on April 30, 2024 that it swung to a consolidated net loss of JPY 5.5 billion in fiscal 2023 as the anemic chip market caused a sales drop. It is the company's first net loss since fiscal 2020. JSR is expected to be delisted from the Tokyo Stock Exchange's top-tier Prime section around summer after the recent completion of a tender offer by government-backed Japan Investment Corp. Aankondiging • May 01
JSR Corporation, Annual General Meeting, Jun 27, 2024 JSR Corporation, Annual General Meeting, Jun 27, 2024. Aankondiging • Apr 19
JSR Corporation to Report Q4, 2024 Results on Apr 30, 2024 JSR Corporation announced that they will report Q4, 2024 results on Apr 30, 2024 Aankondiging • Apr 18
Nikkei to Remove JSR from Semiconductor Stock Index, Probability of Delisting the Stock Nikkei will remove Tokyo-based chipmaking materials producer JSR Corporation from its Nikkei Semiconductor Stock Index on May 1, the company said on April 17, 2024. The index provider said in a statement, "The probability of delisting the stock is extremely high, based on the results of the tender offer bid," referring to a buyout offer from government-backed fund Japan Investment Corp. that closed on April 16, 2024. Nikkei said the index's constituents will remain at 29 issues until November, when it plans a periodic review of the index's constituents. The index was first launched with 30 stocks in March. Major Estimate Revision • Apr 17
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥71.26 to JP¥63.49. Revenue forecast unchanged from JP¥411.7b at last update. Net income forecast to grow 1,537% next year vs 19% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥4,150 unchanged from last update. Share price was steady at JP¥4,333 over the past week. Major Estimate Revision • Feb 22
Consensus EPS estimates fall by 12% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥81.04 to JP¥71.26 per share. Revenue forecast steady at JP¥413.0b. Net income forecast to grow 1,612% next year vs 21% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥4,150 unchanged from last update. Share price was steady at JP¥4,041 over the past week. Reported Earnings • Feb 06
Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2024 results: EPS: JP¥36.16 (up from JP¥23.36 in 3Q 2023). Revenue: JP¥121.1b (up 4.6% from 3Q 2023). Net income: JP¥7.51b (up 55% from 3Q 2023). Profit margin: 6.2% (up from 4.2% in 3Q 2023). Revenue exceeded analyst estimates by 9.4%. Earnings per share (EPS) missed analyst estimates by 6.2%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jan 11
Price target increased by 8.1% to JP¥4,167 Up from JP¥3,854, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥4,058. The company is forecast to post earnings per share of JP¥107 for next year compared to JP¥75.56 last year. Aankondiging • Dec 23
JSR Corporation to Report Q3, 2024 Results on Feb 05, 2024 JSR Corporation announced that they will report Q3, 2024 results on Feb 05, 2024 Reported Earnings • Nov 07
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: JP¥2.12 (down from JP¥43.37 in 2Q 2023). Revenue: JP¥95.7b (down 7.9% from 2Q 2023). Net income: JP¥439.0m (down 95% from 2Q 2023). Profit margin: 0.5% (down from 8.7% in 2Q 2023). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 92%. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. New Risk • Aug 08
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (195% payout ratio). Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Reported Earnings • Aug 08
First quarter 2024 earnings: EPS and revenues miss analyst expectations First quarter 2024 results: JP¥12.44 loss per share (down from JP¥27.09 profit in 1Q 2023). Revenue: JP¥85.0b (down 8.8% from 1Q 2023). Net loss: JP¥2.58b (down 145% from profit in 1Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Aankondiging • Aug 07
JSR Corporation to Report Q2, 2024 Results on Nov 06, 2023 JSR Corporation announced that they will report Q2, 2024 results on Nov 06, 2023 Aankondiging • Jun 28
JICC-02 Co., Ltd. made a tender offer to acquire JSR Corporation (TSE:4185) for approximately ¥900 billion. JICC-02 Co., Ltd. made a tender offer to acquire JSR Corporation (TSE:4185) for approximately ¥900 billion on June 26, 2023. The offer price per share is ¥4,350 cash per JSR share. Once the tender offer is completed, JSR will be delisted through squeeze out procedures and will be a wholly-owned subsidiary of the offeror. The transaction is subject to minimum tender acceptance of 138,531,400 shares, representing 66.67% stake in JSR. The JSR Board of Directors and Special Committee, consisting of JSR’s independent outside directors unanimously recommended the shareholders to approve the offer. The tender offer is expected to be commenced by late December 2023. New Risk • Jun 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 93% Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Profit margins are more than 30% lower than last year (3.9% net profit margin). Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to JP¥3,934, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 106% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥3,556 per share. Aankondiging • May 31
JSR Corporation to Report Q1, 2024 Results on Aug 07, 2023 JSR Corporation announced that they will report Q1, 2024 results on Aug 07, 2023 Aankondiging • May 10
JSR Corporation Announces Resignation of Nobuo Kawahashi as Director JSR Corporation at the Board of Directors meeting held on May 9, 2023 decided, resignation of Nobuo Kawahashi as Director. Reported Earnings • Apr 29
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: JP¥75.56 (down from JP¥163 in FY 2022). Revenue: JP¥408.9b (up 20% from FY 2022). Net income: JP¥15.8b (down 55% from FY 2022). Profit margin: 3.9% (down from 10% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 38%. Revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥35.00 per share at 2.3% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 20 June 2023. Payout ratio is a comfortable 64% but the company is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.8%). Reported Earnings • Feb 10
Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2023 results: EPS: JP¥23.33 (down from JP¥72.02 in 3Q 2022). Revenue: JP¥115.7b (up 31% from 3Q 2022). Net income: JP¥4.85b (down 69% from 3Q 2022). Profit margin: 4.2% (down from 18% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) missed analyst estimates by 38%. Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year. Aankondiging • Feb 07
JSR Corporation Revises Earnings Guidance for the Fiscal Year Ending March 31, 2023 JSR Corporation revised earnings guidance for the fiscal year ending March 31, 2023. For the year ending March 31, 2023, the company revised revenue of JPY 411,000 million compared to previous guidance of JPY 420,500 million, Operating profit of JPY 34,500 million compared to previous guidance of JPY 56,000 million, Profit Attributable to owners of parent of JPY 24,000 million compared to previous guidance of JPY 43,500 million or Basic EPS of JPY 115.63 compared to previous forecast of JPY 209.57. Buying Opportunity • Jan 27
Now 20% undervalued Over the last 90 days, the stock is up 5.8%. The fair value is estimated to be JP¥3,663, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 11% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 7.6% per annum. Earnings is also forecast to grow by 14% per annum over the same time period. Aankondiging • Jan 12
JSR Corporation (TSE:4185) completed the acquisition of remaining 60% stake in JSR Electronic Materials Korea Co.,Ltd from PERI Corporation. JSR Corporation (TSE:4185) agreed to acquire remaining 60% stake in JSR Electronic Materials Korea Co.,Ltd from PERI Corporation on October 13, 2022.JSR Corporation (TSE:4185) completed the acquisition of remaining 60% stake in JSR Electronic Materials Korea Co.,Ltd from PERI Corporation on January 10, 2023. Board Change • Nov 16
Less than half of directors are independent There are 9 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. 4 independent directors (5 non-independent directors). Representative Director & CEO Eric R. Johnson is the most experienced director on the board, commencing their role in 2019. Independent Outside Director Kazuo Ushida was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Aankondiging • Nov 07
JSR Corporation to Report Q3, 2023 Results on Feb 06, 2023 JSR Corporation announced that they will report Q3, 2023 results on Feb 06, 2023 Reported Earnings • Nov 02
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2023 results: EPS: JP¥43.37 (up from JP¥38.79 in 2Q 2022). Revenue: JP¥104.0b (up 21% from 2Q 2022). Net income: JP¥9.03b (up 8.2% from 2Q 2022). Profit margin: 8.7% (down from 9.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 4.6%. Revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥35.00 per share Eligible shareholders must have bought the stock before 29 September 2022. Payment date: 08 December 2022. Payout ratio is a comfortable 46% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.7%). Lower than average of industry peers (2.9%). Reported Earnings • Aug 02
First quarter 2023 earnings: EPS and revenues miss analyst expectations First quarter 2023 results: EPS: JP¥27.09 (down from JP¥36.55 in 1Q 2022). Revenue: JP¥93.3b (up 13% from 1Q 2022). Net income: JP¥5.74b (down 27% from 1Q 2022). Profit margin: 6.2% (down from 9.5% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.4%. Earnings per share (EPS) also missed analyst estimates by 43%. Over the next year, revenue is forecast to grow 9.2%, compared to a 10.0% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 02
Investor sentiment deteriorated over the past week After last week's 16% share price decline to JP¥3,070, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 9x in the Chemicals industry in Japan. Total returns to shareholders of 96% over the past three years. Reported Earnings • Jun 22
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: JP¥163 (up from JP¥257 loss in FY 2021). Revenue: JP¥341.0b (down 24% from FY 2021). Net income: JP¥35.0b (up JP¥90.2b from FY 2021). Profit margin: 10% (up from net loss in FY 2021). The move to profitability was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.8%. Over the next year, revenue is forecast to grow 15%, compared to a 11% growth forecast for the industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 96 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment deteriorated over the past week After last week's 16% share price decline to JP¥3,485, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 10x in the Chemicals industry in Japan. Total returns to shareholders of 130% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥6,750 per share. Reported Earnings • Apr 27
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: JP¥163 (up from JP¥257 loss in FY 2021). Revenue: JP¥341.0b (down 24% from FY 2021). Net income: JP¥35.0b (up JP¥90.2b from FY 2021). Profit margin: 10% (up from net loss in FY 2021). The move to profitability was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.8%. Over the next year, revenue is forecast to grow 12%, compared to a 9.7% growth forecast for the industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 96 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Outside Director Rob Hale was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥35.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 18 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%). Buying Opportunity • Mar 11
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 24%. The fair value is estimated to be JP¥4,180, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.2% per annum over the last 3 years. The company became loss making over the last year. Reported Earnings • Feb 02
Third quarter 2022 earnings: EPS exceeds analyst expectations Third quarter 2022 results: EPS: JP¥72.02 (up from JP¥34.20 in 3Q 2021). Revenue: JP¥88.4b (down 28% from 3Q 2021). Net income: JP¥15.5b (up 111% from 3Q 2021). Profit margin: 18% (up from 6.0% in 3Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 102%. Over the next year, revenue is expected to shrink by 5.3% compared to a 7.3% growth forecast for the industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 129 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 10
Second quarter 2022 earnings released: EPS JP¥38.79 (vs JP¥8.40 loss in 2Q 2021) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2022 results: Revenue: JP¥85.9b (down 15% from 2Q 2021). Net income: JP¥8.34b (up JP¥10.1b from 2Q 2021). Profit margin: 9.7% (up from net loss in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 130 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥30.00 per share Eligible shareholders must have bought the stock before 29 September 2021. Payment date: 27 November 2021. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%). Reported Earnings • Aug 03
First quarter 2022 earnings released: EPS JP¥36.55 (vs JP¥5.25 in 1Q 2021) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2022 results: Revenue: JP¥82.3b (down 12% from 1Q 2021). Net income: JP¥7.86b (up JP¥6.73b from 1Q 2021). Profit margin: 9.5% (up from 1.2% in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance. Reported Earnings • Jun 21
Full year 2021 earnings released The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: JP¥446.6b (down 5.4% from FY 2020). Net loss: JP¥55.2b (down 347% from profit in FY 2020). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Reported Earnings • Apr 28
Full year 2021 earnings released: JP¥257 loss per share (vs JP¥103 profit in FY 2020) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: JP¥446.6b (down 5.4% from FY 2020). Net loss: JP¥55.2b (down 347% from profit in FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥30.00 per share Eligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.7%. Lower than top quartile of Japanese dividend payers (2.7%). In line with average of industry peers (1.8%). Is New 90 Day High Low • Mar 12
New 90-day high: JP¥3,495 The company is up 24% from its price of JP¥2,816 on 11 December 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥3,550 per share. Reported Earnings • Feb 11
Third quarter 2021 earnings released: EPS JP¥34.20 (vs JP¥25.49 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥122.7b (up 3.2% from 3Q 2020). Net income: JP¥7.35b (up 34% from 3Q 2020). Profit margin: 6.0% (up from 4.6% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Feb 10
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 13%. Earnings per share (EPS) also surpassed analyst estimates by 41%. Over the next year, revenue is forecast to grow 7.5%, compared to a 6.4% growth forecast for the Chemicals industry in Japan. Price Target Changed • Jan 29
Price target raised to JP¥3,262 Up from JP¥3,042, the current price target is an average from 12 analysts. The new target price is close to the current share price of JP¥3,195. As of last close, the stock is up 61% over the past year. Price Target Changed • Jan 26
Price target raised to JP¥3,207 Up from JP¥2,957, the current price target is an average from 12 analysts. The new target price is 6.9% below the current share price of JP¥3,445. As of last close, the stock is up 71% over the past year. Analyst Estimate Surprise Post Earnings • Jan 26
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 13%. Earnings per share (EPS) also surpassed analyst estimates by 41%. Over the next year, revenue is forecast to grow 6.7%, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Is New 90 Day High Low • Jan 20
New 90-day high: JP¥3,185 The company is up 26% from its price of JP¥2,530 on 22 October 2020. The Japanese market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥3,431 per share. Price Target Changed • Jan 13
Price target raised to JP¥2,957 Up from JP¥2,745, the current price target is an average from 12 analysts. The new target price is close to the current share price of JP¥3,085. As of last close, the stock is up 50% over the past year. Is New 90 Day High Low • Jan 05
New 90-day high: JP¥2,930 The company is up 17% from its price of JP¥2,513 on 07 October 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥3,420 per share. Is New 90 Day High Low • Dec 01
New 90-day high: JP¥2,929 The company is up 28% from its price of JP¥2,289 on 02 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥2,934 per share.